Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02556554 · ClinicalTrials.gov registry record · NA

Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy

A NA study of Diabetes Mellitus, Type I, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT02556554 is a NA study of Diabetes Mellitus, Type I that has completed, run by University of Colorado, Denver. The registered enrollment target is 67 participants, below the 138-participant average among 5 other Diabetes Mellitus, Type I trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02556554, a NA study of Diabetes Mellitus, Type I, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

A single-center, prospective, 'open-label,' investigator-initiated pilot study evaluating the role of continuous glucose monitor (CGM) use either alone or with remote monitoring capabilities during pregnancy associated with T1DM.

Conditions Studied

Interventions

  • DEVICE Dexcom G4 or G5 Platinum CGM system
  • DEVICE Dexcom G4 or G5 Platinum CGM system with Share

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2015-08
Est. Completion 2017-08
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02556554

The ClinicalTrials.gov registry entry for NCT02556554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 5 other Diabetes Mellitus, Type I trials with a reported enrollment target (51% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type I appearing as the primary indexed condition, and to 2 interventions - of which Dexcom G4 or G5 Platinum CGM system is the first listed.

NCT02556554 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02556554 about?

NCT02556554 is a clinical study titled "Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy". A single-center, prospective, 'open-label,' investigator-initiated pilot study evaluating the role of continuous glucose monitor (CGM) use either alone or with remote monitoring capabilities during pregnancy associated with T1DM.

What is the current status of trial NCT02556554?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2015-08. Estimated completion is 2017-08.

What conditions does trial NCT02556554 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type I.

What interventions are being tested in trial NCT02556554?

The interventions under investigation include: Dexcom G4 or G5 Platinum CGM system (DEVICE), Dexcom G4 or G5 Platinum CGM system with Share (DEVICE).

Who is sponsoring clinical trial NCT02556554?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02556554 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type I

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.